From CARE
Dishman Pharmaceuticals and Chemicals announced the revision in Ratings for Outstanding Non-Convertible Debenture issue (listed debt instruments) and Credit Rating for Banking Facilities of the Company by CARE Rating Agency.Long Term Bank Facilities (Rs 288.66 crore) - CARE BBB+
Long Term/ Short Term Bank Facilities (Rs 91.36 crore) - CARE BBB+/ CARE A3+
Short Term Bank Facilities (Rs 212.27 crore) - CARE A3+
Non-Convertible Debenture issue (Rs 97.50 crore) - CARE BBB+
Powered by Capital Market - Live News